First Federal Trial For Xarelto Bleeding Lawsuit To Begin In March

   

Xarelto Bleeding Lawsuit Filings Allege The Anticoagulant Causes Brain Bleeds, Strokes, Gastrointestinal Bleeds, And Other Serious Side Effects.

Xarelto-Lawsuits-Southern-Med-Law-AttorneyA federal Xarelto bleeding lawsuit alleging gastrointestinal bleeding after use of the prescription blood thinner is scheduled for trial in March. This is the first Xarelto case to go to trial since federal Xarelto lawsuits were consolidated in December 2014. The Xarelto complaints pending in multidistrict litigation (MDL) in the U.S. District Court, Eastern District of Louisiana allege that Bayer and Janssen Pharmaceuticals Inc., which manufactures and markets Xarelto, failed to adequately warn that the blood thinner can cause such side effects as gastrointestinal bleeding, brain bleeds, hemorrhagic stroke, and death. (In Re: Xarelto Products Liability Litigation, No. 2592)

The first Xarelto trial is scheduled to begin March 13 at the federal courthouse in Louisiana. The Xarelto lawsuit selected for trial involves a Louisiana man who said he was prescribed Xarelto in January 2014 to reduce the risk of stroke due to atrial fibrillation. Less than a month after taking Xarelto, the plaintiff suffered gastrointestinal bleeding and was hospitalized and received several blood transfusions, according to the complaint. (Case No. 2:14-cv-02720, In Re: Xarelto Products Liability Litigation, No. 2592)

“We are pleased that a jury will finally hear about Xarelto’s bleeding side-effects and we will be monitoring this trial very closely,” says Dr. François Blaudeau, attorney and founder of Southern Med Law.

The Xarelto bleeding lawsuit attorneys at Southern Med Law are strong advocates of helping patients who believe they have suffered Xarelto side effects. The firm has spoken with men and women from across the country who are believed to have experienced serious bleeding events after taking Xarelto. If you or a loved one experienced life-threatening internal bleeding or other complications allegedly associated with Xarelto, please contact the Firm to learn more about your legal rights and to arrange for a free, no obligation Xarelto lawsuit review by calling Southern Med Law today, at 205-547-5525 or visit www.southernmedlaw.com for more information and to fill out a contact form.

Xarelto (rivaroxaban) is a prescription anticoagulant approved in July 2011 by the U.S. Food and Drug Administration (FDA) to reduce the risk of deep vein thrombosis and pulmonary embolism from occurring after hip or knee replacement surgery. The FDA further expanded Xarelto’s approval to reduce the risk of stroke in patients with atrial fibrillation not caused by a heart valve problem and to treat deep vein thrombosis and pulmonary embolism.
[fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326654.htm, FDA]

Xarelto’s website promotes the medication as the number one prescribed blood thinner in its class with more than 21 million Xarelto prescriptions written in the United States. Patients taking Xarelto do not undergo routine blood monitoring as do patients taking the blood thinner, warfarin, (Coumadin, Jantoven). Unlike warfarin, Xarelto does not have an approved reversal agent to counteract its anticoagulation effects, according to the FDA. Warfarin uses vitamin K as an antidote for internal bleeding.
[xarelto-us.com/dvt-pe]
[fda.gov/Drugs/NewsEvents/ucm405148.htm, FDA]

In August, U.S. District Judge Eldon, who is managing the Xarelto MDL, selected four Xarelto bleeding side-effects lawsuits for trial, court records show. The second Xarelto case, scheduled for trial in Louisiana on April 24, alleges the plaintiff suffered gastrointestinal bleeding after taking Xarelto. The third case, to take place in the Southern District of Mississippi on May 30, alleges the blood thinner caused a brain bleed that resulted in death. A date for the fourth Xarelto trial has yet to be scheduled. (Case No. 2:14-cv-02720, In Re: Xarelto Products Liability Litigation, No. 2592)

About Southern Med Law And Filing A Xarelto Bleeding Lawsuit

Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made the Southern Med Law team an aggressive and effective attorney and advocate for those who were harmed due to negligent pharmaceutical companies. If you or a loved one believe they where harmed by Xarelto, please contact Southern Med Law today to learn more about your legal rights. Call today for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525
Fax: 205-547-5526
francois@southernmedlaw.com

This entry was posted in Southern Med Law | Article. Bookmark the permalink.